Related Experiment Video

Updated: Jun 3, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Challenges for development of meningococcal vaccines in infants and children

Alice Deasy1, Robert C Read

  • 1Infection and Immunity Department, University of Sheffield Medical School, Beech Hill Road, Sheffield, S10 2RX, UK.

Expert Review of Vaccines
|March 26, 2011
PubMed

Insights

Infants are highly susceptible to meningococcal disease. Current vaccines offer limited long-term protection in young children, necessitating improved strategies for infant immunization against this serious infection.

Area of Science:

  • Bacteriology
  • Immunology
  • Vaccinology

Background:

  • Neisseria meningitidis causes severe sepsis and meningitis, with infants facing higher risks due to immature immune systems.
  • Existing meningococcal vaccines, including conjugate types, provide suboptimal and waning protection in infants, requiring multiple doses and boosters.

Purpose of the Study:

  • To review the epidemiology of meningococcal disease in infants by age and serogroup.
  • To explore the reasons behind the poor immunogenicity of current vaccines in this vulnerable population.
  • To discuss strategies for enhancing infant protection against meningococcal infections.

Main Methods:

  • Literature review of current epidemiology of meningococcal disease in infants.
  • Analysis of immunogenicity and efficacy data for various meningococcal vaccine types in young children.
  • Discussion of immunological factors contributing to vaccine unresponsiveness in infants.

Main Results:

  • Infants exhibit unique immunological challenges impacting vaccine responses.
  • Current conjugate vaccines necessitate complex dosing schedules and still show waning immunity over time.
  • Significant variations exist in vaccine efficacy across different meningococcal serogroups in infants.

Conclusions:

  • Optimizing infant immunization against meningococcal disease requires addressing the specific immunological hurdles in this age group.
  • Development of novel vaccine platforms or strategies is crucial for achieving sustained protection.
  • Further research into infant immune responses to vaccination is essential for improving public health outcomes.

More Related Videos

Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat08:27

Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat

Published on: October 29, 2014

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...